Impf-Info - der blog
Valneva - booster-Studie vor Marktzulassung
Valneva to launch trial for booster use of its COVID-19 vaccine candidate | Reuters
French drugmaker Valneva said on Wednesday it will conduct a trial about the use of its COVID-19 vaccine candidate VLA2001 as a booster jab following a mRNA vaccination or natural infection.
By accepting you will be accessing a service provided by a third-party external to https://www.impf-info.de/